Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Total Non-Current Liabilities: 2017-2024

Historic Total Non-Current Liabilities for Organogenesis Holdings (ORGO) over the last 8 years, with Dec 2024 value amounting to $111.7 million.

  • Organogenesis Holdings' Total Non-Current Liabilities fell 27.10% to $121.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $121.3 million, marking a year-over-year decrease of 27.10%. This contributed to the annual value of $111.7 million for FY2024, which is 38.01% down from last year.
  • Latest data reveals that Organogenesis Holdings reported Total Non-Current Liabilities of $111.7 million as of FY2024, which was down 38.01% from $180.1 million recorded in FY2023.
  • Organogenesis Holdings' 5-year Total Non-Current Liabilities high stood at $200.4 million for FY2021, and its period low was $111.7 million during FY2024.
  • For the 3-year period, Organogenesis Holdings' Total Non-Current Liabilities averaged around $158.1 million, with its median value being $180.1 million (2023).
  • Per our database at Business Quant, Organogenesis Holdings' Total Non-Current Liabilities spiked by 42.67% in 2021 and then tumbled by 38.01% in 2024.
  • Organogenesis Holdings' Total Non-Current Liabilities (Yearly) stood at $140.4 million in 2020, then soared by 42.67% to $200.4 million in 2021, then declined by 8.88% to $182.6 million in 2022, then decreased by 1.32% to $180.1 million in 2023, then plummeted by 38.01% to $111.7 million in 2024.